Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-27 @ 10:18 PM
Study NCT ID:
NCT00375661
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2006-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC
Sponsor:
Kyoto University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2012-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-12
First Submit QC Date:
None
Study First Post Date:
2006-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-01
Last Update Post Date:
2015-09-02
Last Update Post Date Type:
ESTIMATED